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Abstract 
Bodipy-verapamil has been tested as a fluorescent substrate for P-glycoprotein-mediated ransepithelial secretion in MDCK-C5A 
epithelia. Net transepithelial secretion (Jnet) of [3H]vinblastine from basal-to-apical surfaces of monolayer epithelia is inhibited by 
taxotere, verapamil and Bodipy-verapamil primarily by a reduction in basal to apical vinblastine (Jb-a) transport. Bodipy-verapamil is 
itself subject o transepithelial net secretion by MDCK-C5A epithelia; at 5 /zM a Jnet of --310___ 32 nmol cm 2 h-~ (n = 3) was 
observed. When MDCK-C5A cells are grown to form enclosed cysts in hydrated collagen gel, Bodipy-verapamil is accumulated within 
the cyst lumen showing that epithelial P-glycoprotein function may be used to target substrates torenal cysts. 
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1. Introduction 
Cystic disease of the kidney is a major cause of renal 
failure. Autosomal dominant polycystic disease is associ- 
ated with the formation in the renal parenchyma of en- 
closed fluid filled cysts [1,2]. The mechanism of fluid 
secretion and renal cyst expansion has been the subject of 
increasing study in order to indicate potential therapeutic 
opportunities [1,2]. Growth of renal epithelial cells in vitro 
within hydrated collagen gels is associated with the forma- 
tion of cysts [1,2]. Salt and fluid secretion across the 
epithelial wall is associated with cyst enlargement; stimu- 
lation of epithelial fluid secretion by agents that raise 
intracellular cAMP such as forskolin, dibutyryl cAMP, 
arginine vasopressin, PGE~, PGE 2 and cholera toxin is 
associated with increased cyst size and fluid secretion 
[1,3]. Inhibition of fluid secretion by ion transport in- 
hibitors such as ouabain, amiloride and the stillbene, DIDS, 
have been documented [4]. Recently it has been shown, 
using in vitro cyst assays, that whilst inhibitors of DNA, 
RNA and protein synthesis do not prevent cyst formation, 
the microtubule inhibitors colchicine, vinblastine and taxol 
are effective [5]. In an in vivo recessive mouse model 
(cpk) of congenital polycystic disease, taxol was also able 
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to prevent uraemic death of homozygous (cpk/cpk) ani- 
mals with treated animals reaching normal size and with 
minimal loss of renal function [5]. 
P-glycoprotein is a 170-180 kDa membrane glyco- 
protein associated with the phenomenon of pleiotropic 
(multidrug) resistance (MDR). Substrates include a variety 
of cytotoxic agents such as colchicine, vinblastine and 
taxol [6]. Immunohistochemical techniques have demon- 
strated the presence of P-glycoprotein i the apical regions 
of several natural epithelia [7-10], including the kidney. 
Renal epithelial cell-lines capable of reforming intact ep- 
ithelial layers when grown upon permeable matrices (e.g., 
MDCK, LLCPKI) mediate pithelial secretion (from basal 
to apical cell surfaces) of P-glycoprotein substrates such as 
vinblastine [11-14]. Retroviral transfection of the dog 
kidney epithelial cell-line (MDCK) with mdrl cDNA re- 
sults in polarised expression of P-glycoprotein to the apical 
plasma membrane domain [15] and an enhanced trans- 
epithelial secretion of vinblastine above intrinsic levels. 
The purpose of the present investigation was to determine 
if P-glycoprotein substrate transport could act to concen- 
trate substrates for P-glycoprotein within cyst fluid so 
acting as a long-term reservoir. 
We have chosen to examine transepithelial secretion of 
MDR substrates in a clonal MDCK line selected for its 
ability to form fluid-filled cysts when cultured within a 
hydrated collagen gel [16]. We show that this cell-line 
when reconstituted as a monolayer will maintain a highly 
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polarised secretion of the MDR substrate vinblastine and 
that this is inhibited by verapamil, dideoxyforskolin and 
taxotere (a structural analogue of taxol, [ 17]). Moreover, a 
fluorescent verapamil derivative (Bodipy-verapamil) [18] 
inhibits vinblastine secretion, whilst being subject o trans- 
epithelial secretion itself. In MDCK cysts confocal aser- 
scanning microscopy of Bodipy-verapamil has been used 
to directly demonstrate accumulation within the cyst lumen 
after incubation, whilst there is retention within the cyst 
fluid after washing and incubation in substrate-free 
medium. The effective targeting and retention of P-glyco- 
protein substrates to renal cysts is likely to be an important 
factor in the efficiency of P-glycoprotein substrates such as 
vinblastine and taxol to inhibit cyst formation in vitro and 
in vivo [5]. 
2. Materials and methods 
2.1. Materials 
[3H]Vinblastine sulfate was purchased from Amersham 
International (Little Chalfont, Amersham, Bucks). 
Bodipy-verapamil was from Molecular Probes (Eugene, 
Oregon). Taxotere was a gift from Dr. J.L. Fabre, Rh6ne- 
Poulenc Rorer, Vitry-sur-Seine, France. All tissue culture 
media and reagents (Gibco BRL) and tissue culture plas- 
tics including tissue culture inserts (Nunc) were supplied 
by Life Technologies (Paisley, UK). All other chemicals 
were obtained from Sigma (Poole, Dorset) or BDH Chemi- 
cals (Poole, Dorset). 
2.2. Cell culture 
A cloned MDCK Strain C5A was a gift from Prof. J.J. 
Grantham (University of Kansas Medical Center, Kansas) 
[16]. MDCK-C5A has enhanced ability to form cysts in 
hydrated collagen gel, in the absence of cystogens. 
MDCK-C5A cells were cultured in minimum essential 
medium (Earle's salts) (MEME) supplemented with 10% 
(v/v)  fetal calf serum, kanamycin antibiotic (1 /xg/ml), 
non-essential amino acids and 2 mM glutamine. Stock 
cultures were subcultured every 7 days, by treatment with 
0.05% trypsin and 0.2% EDTA in CaZ+-and Mg2+-free 
phosphate-buffered saline. Epithelial ayers were prepared 
by high-density seeding (10  6 cells/cm 2) onto Nunc 
Anopore 25 mm culture inserts 4 cm -2 growth area. 
Epithelia were used 2-3 d after seeding, after trans- 
epithelial resistance (Rt), exceeded 750 ~ cm 2 measured 
using a WPI Evometer. 
MDCK-C5A cysts were prepared by seeding (0.3 • 10 6 
cells/ml) into liquid collagen (prepared from rat 
tails)/MEME before gel formation [19]. All cultures were 
incubated at 37°C in a humidified atmosphere of 5% 
CO2/95% air. 
2.3. Transport experiments 
Measurements of transepithelial solute flux were made 
essentially as described previously [ 12,13]. Briefly, the cell 
monolayers were extensively washed (four times in 500 ml 
of modified Krebs buffer of composition, all mmol/l: 
NaC1, 140; KCI, 5.4; CaCI 2, 2.8; MgSO 4, 1.2; NaHzPO 4, 
0.3; KH2PO 4, 0.3; Hepes, 10; glucose, 5 (pH to 7.5 at 
37°C with Tris base)), placed in 6-well plates, each well 
containing 2 ml of prewarmed modified Krebs. Aliquots of 
Krebs buffer were then placed in the upper filter cup 
(apical solution). Radiolabelled vinblastine was used at 
tracer concentrations (0.25 /zCi/ml, 8-12 nM); Bodipy- 
verapamil was used alone or in conjunction with vinblas- 
tine at 1-10 /xM. Matched pairs of epithelial layers were 
used to trace either apical-to-basal solute (vinblastine and 
or Bodipy-verapamil) flux (J~-b) or basal-to-apical flux 
(Jb_a). Aliquots (200 /zl) of fluid from each chamber were 
removed at predetermined times (1-3 h) for determination 
of 3H activities (dpm) by liquid scintillation spectrometry, 
with appropriate corrections for quench and efficiency, 
using a Beckman LS 5000CE. The concentration of Bod- 
ipy-verapamil in sample aliquots was determined by fluo- 
rescence spectroscopy (Perkin-Elmer luminescence LS-5 
spectrometer, xcitation 480 nm, emission 510 nm). Solute 
permeation across the monolayers into the contralateral 
chamber is expressed as flux mol cm -2 h -j or as a 
permeability (Pa-b =Ja-JCa),  where C is the concentra- 
tion of solute in the ipsilateral chamber. At the end of the 
incubation period cell monolayers were washed in 4 X 500 
ml volumes of ice-cold Krebs buffer (pH 7.5) to remove 
any loosely-associated radiolabel, and removed from the 
insert. Cell monolayer-associated ra iolabel was deter- 
mined by solubilisation in scintillation fluid and scintilla- 
tion counting. Cellular accumulation of vinblastine is ex- 
pressed as mM or as a cell to solution (C /M)  ratio. 
2.4. Microscopy 
Renal cysts in hydrated collagen gel were visualised 
directly by confocal laser scanning microscopy (CLSM, 
Bio-Rad MRC-600, argon-ion laser, Hemel Hempstead, 
U.K., attached to a Nikon Diaphot microscope). The objec- 
tive used was a Nikon oil immersion ×60, numerical 
aperture 1.4 giving an optical section of approx. 1 p~m 
depth. Cell height was determined by confocal imaging of 
intact cell layers and this value was used in the determina- 
tion of intracellular water for calculation of C/M ratios. 
2.5. Statistics 
Data are expressed as means +_ S.E. of n replicates. 
Tests of significance of differences between mean values 
were made using a two-tailed Student's t-test (for paired or 
unpaired mean data) or Mann-Whitney U-tests (two-tailed 
tests, unpaired ata), where appropriate. 
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3. Results 
MDCK-C5A epithelia have high electrical resistance 
(2451 ___ 194 (S.E.) n = 24 1-2 cm 2, note that values of 
resistance for filter cups, 300 12 cm 2 are subtracted from 
all data), similar to Strain 1-MDCK and typical of 'tight' 
epithelia [12]. This ability to form an epithelial barrier is 
also evident in the ability of MDCK-C5A epithelia to 
maintain a marked asymmetry in the bidirectional trans- 
epithelial fluxes of vinblastine. Jb-~ (0.325-t-0.09 nmol 
cm -2 h-  1 (n = 6)) exceeds Ja-b (0.006 ___ 0.001 nmol cm 2 
h - j  (n = 6) P < 0.001) (Fig. 1), indicating a significant 
net secretion of vinblastine from basal to apical surfaces. 
In control conditions and in the presence of vinblastine the 
spontaneous transepithelial electrical p.d. is low (< 1 mV 
basal solution electro-positive) for MDCK-C5A epithelia. 
The observed asymmetry for vinblastine flux (Jb_a/Ja_b = 
58.0) cannot be accounted for by passive electrical forces 
and must represent active transport by the epithelium. 
Both verapamil (100 /zM) and taxotere (10 /xM) pre- 
sent in both bathing solutions effectively abolish the net 
secretion of vinblastine by reducing the permeability of 
vinblastine in the secretory direction Pb-a towards P~-b 
(Fig. 1) and increasing Pa-b (Fig. 1). Bodipy-verapamil is a 
fluorescent analog of verapamil which retains the ability to 
competitively inhibit vinblastine secretion, being of similar 
molar potency to taxotere (Fig. 1). In addition to being a 
competitive inhibitor of P-glycoprotein function, Bodipy- 
verapamil is itself subject to epithelial secretion by 
MDCK-C5A epithelia. At 1 /zM Bodipy-verapamil Jb-a 
(37.7 + 4.5 nmol cm -2 h 1 (n --- 9)) exceeds Ja-b (2.9 ___ 
0.3 nmolcm : h - l  (n=9)  P<0.001) ,  a 13-foldasym- 
metry. Both the unidirectional absorptive permeability for 
Bodipy-verapamil P~-b ((0.29 __+ 0.04)- 10 -2 cm h-  l n = 
3), and that for vinblastine ((0.047 +0.005) -10  -2 cm 
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Fig. 1. Transepithelial vinblastine sulphate permeabilities measured in 
MDCK-C5A epithelial layers. [3H]Vinblastine flux was measured in the 
basolateral-to-apical (b-a) (open bars), and in the apical-to-basolateral 
(a-b) (hatched bars) directions in control conditions and in the presence of 
10/zM taxotere, 100/xM verapamil and 10/zM Bodipy-verapamil added 
to both apical and basal bathing solutions. Data are mean values + S.E. 
from three to six separate pithelial layers. 
h - I ,  n = 6), are low compared to that for the secretory 
permeability for Bodipy-verapamil Pb-~ ((3.7 + 0.4)" 10 -2 
cm h -1 n = 3), and vinblastine ((3.95 + 0.25). 10 -2 cm 
h-  1, n = 6). Apparent saturation of net secretion of Bod- 
ipy-verapamil concentration is observed; at 5 /zM J, et of 
-310- t -32nmolcm -2 h -~ n = 3 is similar to that at 10 
/~M ( -345  _% 38 nmol cm 2 h - I  n=3) .  Net Bodipy- 
verapamil secretion at 1 /zM ( -34 .5  ___ 3.4 nmol cm -~ 
h ~) is subject to competitive inhibition by 20 /zM 
dideoxyforskolin (to - 23.4 + 1.9 nmol cm 2 h-  1, p < 
0.05), and 20 /zM taxotere (to -5 .7  ___ 0.2 nmol cm 2 
h -~, P<0.01)  added to both apical and basal bathing 
solutions. 
The cellular accumulation of [3H]vinblastine from ei- 
ther the apical or basal bathing solutions of MDCK-C5A 
epithelia, also shows asymmetry, accumulation across the 
basal cell aspects (C/M 7.3 + 0.8, n = 3) exceeding that 
across the apical cell aspects (C/M 0.4 _+ 0.1). This is in 
agreement o that found previously [11]. Inhibition of 
P-glycoprotein function is associated with increased cellu- 
lar accumulation of vinblastine; 10 /zM taxotere (added to 
both bathing solutions) increases C/M across the basal 
surface from 22.8 -I- 2.7 (control n = 3) to 63.9 __+ 1.8 P < 
0.01 (paired data). Similarly 10 /zM Bodipy-verapamil 
(added to both bathing solutions) increases C/M from 
7.3 -t- 0.8 to 24.7 -t- 1.6 (P  < 0.01 n = 3, paired data). 
Taken together, these data are consistent with expres- 
sion of P-glycoprotein in MDCK-C5A epithelia and with 
Bodipy-verapamil being an effective substrate for P-glyco- 
protein. 
Fig. 2a shows a series of confocal images through an 
MDCK-C5A cyst grown in hydrated collagen gel after 
incubation with 5 /zM Bodipy-verapamil for 16 h. It is 
apparent hat there is marked intracellular accumulation of 
the fluorophore and this is mainly vesicular in nature. It is 
also apparent that in order to assess whether Bodipy- 
verapamil is accumulated within the cyst lumen it is 
necessary to eliminate fluorescence from out of focus 
structures by an appropriate optical section. Fig. 2b shows 
an optical section which has been placed to transect he 
cyst lumen; by averaging pixel intensity over the whole 
image on a 0-256 scale (including cell fluorescence) and 
then delimiting areas of cyst lumen and extracellular fluid 
over which average pixel intensity is computed, it is 
apparent that an increased average fluorescence intensity is 
observed within the lumen compared (35.7 units/pixel) 
with that in the external medium (20.6 units/pixel). Relat- 
ing the known external concentration to pixel intensity, we 
estimate accumulation of Bodipy-verapamil within the cyst 
lumen in Fig. 2b to be 5.3-fold. Absolute calibration of 
luminal Bodipy-verapamil was not possible since the dark 
current set on control cysts (18.4 units/pixel) was the 
major fraction of intensity levels recorded with external 
Bodipy-verapamil, sometimes exceeding external average 
intensity. After prolonged incubation times (16 h) at 5 /zM 
Bodipy-verapamil of 14 cysts in two separate preparations 
34 N.L. Simmons et al. / Biochimica et Biophysica Acta 1237 (1995) 31-36 
(51-157/zm outer diameter) 13 out of 14 showed signifi- 
cant accumulations with respect to incubation medium. 
Extensive washing and incubation of cysts in Bodipy- 
verapamil free media and incubation for up to 3 h follow- 
ing overnight incubation failed to reduce either cell associ- 
ated Bodipy-verapamil or lumen Bodipy-verapamil (not 
shown), confirming that the effective barrier to equilibra- 
tion afforded by the epithelium observed in monolayer 
culture is maintained within the cyst. Assuming net trans- 
port rates for Bodipy-verapamil observed at 5 /zM for 
intact layers, it can be calculated that equilibration of the 
cyst lumen should be achieved for an 80 /xm cyst within 5 
min. Fig. 3 shows that when cysts are incubated at 0 .5 /zM 
Bodipy-verapamil for 15 min marked accumulation of 
A 
B 
Fig. 2. (A) Series of four CLSM optical sections at 15 /zM steps of a 
single MDCK-C5A cyst (a-d) grown in hydrated collagen gel and 
incubated with 5 /zM Bodipy-verapamil for 16 h in serum free Hams 
F12/DMEM 1:1, Hepes-buffered medium minus Phenol red. Note the 
clear section through the lumen obtained in the second and third images. 
Fluorescence intensity is linear (1-256) Scale bar = 25/zm. (B) Analysis 
of luminal Bodipy-verapamil concentration. Renal cysts were incubated 
for 16 h with 5 /zM Bodipy-verapamil. Average fluorescence intensity 
over the whole image is represented ona 1-256 scale. 0-30 is set as 
black; note that his encompasses the bulk of the collagen gel equilibrated 
with 5 /zM Bodipy-verapamil. 30-256 is coded by the grey-white 
non-linear wedge indicated by the intensity scale at the right of the panel. 
Scale bar = 25 /xM. 
Fig. 3. Analysis of luminal Bodipy-verapamil concentration with short 
incubation. Renal cysts were incubated for 15 min with 0.5 /.~M Bodipy- 
verapamil. Average fluorescence intensity over the whole image is repre- 
sented on a 1-256 scale. 0-20 is set as black; note that his encompasses 
the bulk of the collagen gel equilibrated with 0.5 /xM Bodipy-verapamil. 
20-256 is coded by the grey-white non-linear wedge indicated by the 
intensity scale. Scale bar = 50 p~M in panel (a). (a) Control cyst incu- 
bated without Bodipy-verapamil, (b-d) cysts of differing luminal diame- 
ter. 
Bodipy-verapamil is evident in cysts of smaller diameter; 
the larger cyst shown fails to demonstrate Bodipy- 
verapamil accumulation at this incubation time. 
4. Discussion 
Epithelial expression of P-glycoprotein in the apical 
brush-border of normal epithelial tissues such as intestine 
and kidney has physiological relevance. In intestinal tissue 
it has been suggested that ATP-dependent extrusion of 
P-glycoprotein substrates results in maintenance of an 
effective barrier despite the relative lipophilicity of many 
of these substrates [6,20]. In kidney P-glycoprotein will 
serve to maintain epithelial secretion of substrates such as 
vinblastine for subsequent elimination in urine. Indeed, 
high renal clearance of P-glycoprotein substrates has been 
convincingly documented [21 ]. 
Immunocytochemical evidence suggests that P-glyco- 
protein expression is present in proximal renal tubules 
[8-10]. In situ hybridisations suggest hat renal medullary 
tissue possess P-glycoprotein mRNA levels in excess of 
renal cortex [22]. Thus, it is likely that expression is 
present in more than one renal segment. MDCK epithelial 
cells display antigenic properties consistent with a distal 
tubular or collecting duct location [12]. Since renal cysts 
may arise from several tubular sites [1,3] the expression of 
P-glycoprotein i human renal cystic epithelia will need to 
be explored. 
The present data show that epithelial secretion of P- 
glycoprotein substrates i present in epithelial monolayers 
of MDCK-C5A monolayers, consistent with P-glyco- 
protein expression to the apical membranes of these cells. 
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MDCK-C5A epithelia form effective epithelial barriers 
with high electrical resistance by 2 days post seeding at 
high density. They are thus similar to Strain 1 MDCK 
epithelia [11]. A model for vinblastine secretion by epithe- 
lial layers is passive accumulation of this basic molecule 
across the basolateral membrane driven by the electro- 
chemical gradient, binding (sequestration) of substrate 
within the cystosol followed by ATP-dependent extrusion 
of free cytosolic drug across the apical membrane [11]. 
The observation i MDCK-C5A epithelia of cellular accu- 
mulation of vinblastine across the basal membrane to- 
gether with the action of inhibitors is consistent with this 
model. 
In renal cystic epithelia basic cell polarity is maintained 
[1-3]. The epithelial lining of the cyst displays tight-junc- 
tions, an apical brush-border at the cyst lumen and a 
basolateral membrane opposed to the renal parenchyma (in 
vivo) or to the collagen substrate in vitro [1-5]. However, 
there is evidence that certain membrane proteins such as 
the Na/K-ATPase may be mislocated in cystic renal ep- 
ithelia [23]. The present data show that the P-glycoprotein 
substrate, Bodipy-verapamil, is accumulated avidly within 
the cell cystosol, the fluorescence being vesicular in na- 
ture. Bodipy-verapamil is also accumulated within the 
lumen of renal cysts. This pattern of substrate deposition 
(passive flux at the basolateral membrane driven by the 
electrochemical gradient and resulting in cellular accumu- 
lation, with extrusion against he prevailing electrochemi- 
cal gradient at the apical membrane), is consistent with the 
maintenance of the apical polarised expression of P-glyco- 
protein. Confirmation of this will require the use of dog- 
specific antibodies to P-glycoprotein, or antibodies that 
cross-react with dog P-glycoprotein. It should be noted that 
endogenous levels of P-glycoprotein expression i  MDCK 
cultures required to give the measured level of maximal 
substrate flux may be small compared to intestinal cell-lines 
expressing P-glycoprotein [11,20]. 
The ability of P-glycoprotein totarget substrate delivery 
to the enclosed cyst lumen will provide a reservoir of 
cytotoxic/cytostatic agents. In this study Bodipy-verapa- 
mil is used as a fluorescent marker to trace the deposition 
of a cytotoxic substrate such as vinblastine or taxotere. In 
MDCK cells cytotoxic effects of vinblastine are recorded 
that are enhanced by vinblastine [11] in actively growing 
cultures. The present study has not attempted to investigate 
cytotoxic effects of P-glycoprotein substrates upon cyst 
expansion and integrity. The ability of taxotere to reverse 
cystic disease in an animal model suggests that this may 
also be the case in vivo [5]. The retention of Bodipy- 
verapamil within the cyst after washing suggests that under 
the conditions used here, no frank cytotoxic effect is 
observed with this agent. Clearance of cellular substrate 
after external levels are reduced to zero will be directed to 
the cyst lumen due to the adverse lectrochemical gradient 
at the basolateral membrane and the apical localisation of 
P-glycoprotein. An enclosed cyst may be contrasted to an 
intact tubule where urine flow will remove transported 
substrate to be voided in urine. We have investigated 
retention of Bodipy-verapamil over incubation periods up 
to 3 h; subsequent effects of cytotoxic/cytostatic agents 
on epithelial integrity will need to be explored with longer 
term incubation. 
The size of the renal cyst is likely to be crucial in 
delivery of P-glycoprotein substrates to the cyst to obtain 
optimal therapeutic action. In progressive renal cystic dis- 
ease, cysts are initially small, ultimately being separated 
from the filtering nephron of origin, and progressively 
increase in size, compressing and destroying the renal 
parenchyma [1-3]. From a consideration of cyst 
volume/surface area relationship small cysts will show the 
highest accumulation of substrate after the shortest expo- 
sure to external P-glycoprotein substrates. Thus, it is likely 
that targeted elivery will be optimal in early disease. 
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